Summary: Objective: Among various adverse reactions of atypical antipsychotics, weight gain and impaired glucose tolerance are clinically signiˆcant. The aim of this study is to analyze quantitatively the contributions of various receptors to these antipsychotics-induced adverse reactions based on the receptor occupancy theory.
Introduction
Among various adverse reactions associated with the use of typical antipsychotics, most attention has been paid to extrapyramidal symptoms, while weight gain has received relatively little attention. In contrast, the recent increase in the use of atypical antipsychotics, which scarcely cause extrapyramidal symptoms, has resulted in greater interest in other adverse reactions, such as weight gain.
In schizophrenic patients, as the psychological condition improves, the appetite increases in general, which may lead to an increase in body weight. Therefore, it has been believed that the increase in body weight can be simply explained by the improvement of psychological condition. 1) However, some reports indicate that antipsychotics may be directly responsible. 2, 3) Moreover, the increase in body weight has been reported to be higher with atypical antipsychotics than with typical ones. 4) With regard to the mechanism, possible involvement of blockade of the histamine H1 receptor, 5, 6) serotonin 5-HT2C receptor, 7) and muscarinic acetylcholine (mACh) receptor 8) has been proposed. However, the quantitative contributions of these receptors to the increase in body weight remain to be analyzed.
Moreover, the morbidity rates of hyperglycemia and diabetes mellitus were shown to be higher for schizophrenic patients. 9) Although this may be partially accounted for by genetic factors, it is likely that antipsychotics induce diabetes mellitus. Indeed, conventional typical antipsychotics such as chlorpromazine have been shown to induce diabetes mellitus. [10] [11] [12] Moreover, many cases of impaired glucose tolerance associated with atypical antipsychotics have been reported, 13) though the primary mechanism also remains to be clariˆed. Blockade of the H1 and 5-HT2C receptors by antipsychotics may increase the body weight and weight of fatty tissue, and may result in insulin resistance. 14) Furthermore, blockade of the 5-HT1A receptor or a1 adrenergic receptor may directly decrease insulin secretion 15) or increase blood glucose, 16) respectively. Thus, although various factors have been proposed as mechanisms of weight gain and impaired glucose tolerance associated with antipsychotics, the quantitative contributions of these factors have not been claried. The aim of this study is to analyze quantitatively the contributions of various receptors to antipsychoticsinduced adverse reactions based on receptor occupancy theory.
Methods

Calculation of mean receptor occupancy of drugs:
The receptor occupancy (F; z) is expressed by equation (1).
17)
F＝ CR CR＋Kd ×100
where CR and Kd represent the concentration of unbound drug around the receptor and the dissociation constant for the drug, respectively. The CR and receptor occupancy change with time after oral administration of a drug, so we employed the mean unbound drug concentration near the receptor in the brain as CR. Monitoring of the human brain concentration of unbound drug is experimentally not feasible. However, since protein binding of drugs in cerebrospinal ‰uid (CSF) is negligible, the drug concentration in CSF can be employed as CR in the case that the CSF-to-plasma drug concentration ratio (KpCSF ) is available (equation 2-1).
where AUCss,0-t, AUC0-/ and t represent the area under the plasma concentration time curve over the dosing interval in the steady state, the area under the plasma concentration time curve from zero to inˆnity after single dosing, and the dosing interval, respectively. When KpCSF is not available, CR in the equation (1) is assumed to be equal to the unbound drug concentration in plasma, and can be calculated by using equation .
where fu is the free fraction of drug in plasma. This assumption seems reasonable, because all the antipsychotics dealt with in this study are highly lipophilic, their brain concentrations are in rapid equilibrium with plasma concentrations, [18] [19] [20] [21] [22] [23] [24] and they might not undergo active transport during distribution into the brain. 25) In addition, the AUCs of all the drugs dealt with in this study are proportional to the dose. 20, [26] [27] [28] [29] [30] [31] [32] The concentration of quetiapine (nM) was expressed as quetiapine base (not as quetiapine fumarate that contains two quetiapine bases in one molecule).
In the case of risperidone and thioridazine, their active metabolites, 9-hydroxyrisperidone and mesoridazine, respectively, also bind to the receptors in a competitive manner. 17) Therefore, F of risperidone and thioridazine can be expressed by the following equations (1?):
where CR1, CR2, Kd1 and Kd2 represent the unbound concentration of parent drug, that of the metabolite, the receptor dissociation constant of parent drug and that of the metabolite, respectively. CR1 and CR2 are also assumed to be equal to the unbound drug concentration in plasma. The pharmacokinetic parameters and receptor dissociation constants of antipsychotics were collected from the literature and are listed in Table 1 . When two or more values for the receptor dissociation constant of antipsychotics have been reported, the geometric mean was used.
Analysis of the correlations of receptor occupancy with weight gain and diabetes mellitus for antipsychotics: The two selected indices of antipsychotic-induced weight gain were collected from literature and evaluated. Theˆrst index we employed as the weight gain (kg) is that estimated by Allison et al. 4) based on a meta-analysis of body weight gain at 10 weeks after the start of chlorpromazine, clozapine, ‰uphenazine, haloperidol, molindone, olanzapine, risperidone, sertindole, thioridazine and ziprasidone. The relation between this index and the estimated receptor occupancy of various receptors calculated by using equation (1) or (1?) was analyzed. The receptor occupancy was estimated by substituting the dose-corrected AUC into equation (2-1) or (2-2). When the dose was not given by Allison et al., the mean maintenance dose recommended in the package inserts was employed. The increase in body weight reported by Allison et al. is summarized in Table 2 along with the corresponding doses and estimated mean plasma unbound concentrations (C R ).
The second index we employed is the observed weight gain in clinical trials of atypical antipsychotics. The inclusion criteria were randomized, controlled, doubleblind clinical trials in schizophrenic patients taking atypical antipsychotics based on the protocol of Leucht et al. 33) A literature search was conducted using the search terms``clozapine (Clozaril } ), olanzapine (Zyprexa } ), quetiapine (Seroquel } ), risperidone (Risperdal } ), sertindole (Serdolect } ) and ziprasidone (Geodon } )'' in MEDLINE (1966-Sep W 2003) to collect appropriate clinical trial reports. The changes in the body weight within 6-8 weeks were used for the analysis. Reports dealing with less than 30 patients or overlapping reports were excluded. The data for haloperidol and chlorpromazine, which were often used as typical antipsychotics for comparison, were also included in the analysis. The relation between this index and the estimated receptor occupancy of various receptors calculated by using the equation (1) or (1?) was Conley RR et al. analyzed. The receptor occupancy was estimated from the dose-corrected AUC, as in the case of theˆrst index. Table 3 summarizes the collected clinical trials used for the analysis. The index we employed for the analysis of impaired glucose tolerance is the morbidity rate (z) of type 2 diabetes mellitus in schizophrenic patients during treatment with clozapine, ‰uphenazine, haloperidol, olanzapine and risperidone reported by Zoler. 34) The relation between this index and the estimated receptor occupancy of various receptors calculated by using the equation (1) or (1?) was analyzed. The receptor occupancy was estimated from the dose-corrected AUC, as in the case of theˆrst index. Table 4 summarizes the morbidity rate of type 2 diabetes mellitus according to Zoler 34) and the corresponding doses and estimated mean plasma unbound concentration (CR).
Analysis of the correlations of the receptor occupancies among various receptors: We investigated the confounding between receptor occupancies of various receptors. The mean unbound plasma drug concentration was estimated for the mean clinical maintenance dose of eleven antipsychotics (chlorpromazine, clozapine, ‰uphenazine, haloperidol, molindone, olanzapine, quetiapine, risperidone, sertindole, thioridazine and ziprasidone), and the occupancies of various receptors were calculated using equation (1) or (1?). The confounding of the receptor occupancy among receptors was evaluated.
Statistical analysis: The two-tailed Spearman's rank correlation coe‹cients (r s ) were used for the correlation analysis and P-values of less than 0.05 were considered statistically signiˆcant.
Results
Correlation between receptor occupancies and antipsychotic-induced weight gain: Table 5 shows the correlation coe‹cients between the weight change assessed by Allison et al. using meta-analysis (theˆrst index of weight gain) and the estimated receptor occupancies of antipsychotics. A statistically signiˆcant correlation was observed between the receptor occupancy of mACh or H1 receptor and weight gain (Fig. 1) , but occupancy of other receptors showed no statistically signiˆcant correlation with weight gain.
The correlation coe‹cients between the observed weight gain in the clinical trials (the second index of the weight gain) and the estimated receptor occupancies are also shown in Table 5 . Again, a statistically signiˆcant correlation was observed between the receptor occupancy of mACh or H 1 receptor and the weight gain (Fig. 2) . With this index, statistically signiˆcant correlations were also observed between receptor occupancies of a2, dopamine D2, 5-HT1A and 5-HT2C receptors and weight gain.
Correlation between receptor occupancies and the antipsychotic-induced morbidity rate of type 2 diabetes mellitus: Table 5 shows the correlation coe‹cients between the morbidity rates of type 2 diabetes mellitus according to Zoler and the estimated receptor occupancies of antipsychotics. Similarly high, statistically signiˆcant correlations were observed between the receptor occupancies of H1, mACh and 5-HT2C receptors and the morbidity rate of type 2 diabetes mellitus. On the other hand, there was no statistically signiˆcant correlation between the receptor occupancy of other receptors and the morbidity rate of type 2 diabetes mellitus.
Correlations of receptor occupancies of antipsychotics among receptors: The correlation coe‹cients of the estimated receptor occupancies of eleven antipsychotics between receptors are shown in Table 6 . A high correlation was observed between the receptor occupancies of eleven antipsychotics at mACh and H1 receptors, showing that there is a high degree of confounding between H1 receptor occupancy and mACh receptor occupancy. There were also statistically signiˆcant correlations between other receptor occupancies.
Discussion
Receptor occupancy theory is a useful approach to predict quantitatively the receptor-mediated pharmacological actions by calculating the receptor occupancy of a drug at a speciˆc receptor. Receptor-mediated actions of a variety of drugs can be estimated quantitatively by analysis based on receptor occupancy theory, with reasonable accuracy. 35, 36) In this study, we analyzed the correlation between the receptor occupancy and the weight gain or the morbidity rate of type 2 diabetes mellitus in schizophrenic patients taking various antipsychotics, based on receptor occupancy theory, and demonstrated that the H1 and mACh receptors were most closely related to the weight gain associated with antipsychotics, and H1, mACh and 5-HT2C receptors were most closely related to the morbidity rate of type 2 diabetes mellitus. However, drugs with higher occupancy of H 1 receptor also have higher occupancy of mACh receptor, suggesting potential confounding. Therefore, the blockade of only one of these two receptors may enough to cause the above-mentioned adverse reactions.
With regard to the relation between H 1 receptor blockade and weight gain, it has been reported in humans that repeated administration of antihistamines increases body weight. 5, 6) In rats, antihistamines have been demonstrated to increase the food ingestion rate. 37, 38) In fact, H 1 receptor knockout mice exhibit various physiological changes that may lead to an increase of body weight, such as loss of circadian rhythm, decrease in locomotor activity and suppression of exploratory behavior, 39) as well as increase in fat deposition with a high-fat diet, increased expression of the ob gene, and elevation in blood insulin. 40) An increase in body weight has also been conˆrmed in H1 receptor knockout mice. 41) Leptin is considered to be involved in the abovementioned responses to blockade of the H 1 receptor. In H1 receptor knockout mice, the appetite-suppressive action of leptin is attenuated [40] [41] [42] and the calorigenic action and reduction of body fat by intraventricularly administered leptin are also attenuated. 40) Therefore, it is likely that leptin suppresses the food intake and increases the energy consumption through the H1 receptor in part, and blockade of the H1 receptor attenuates the action of leptin, resulting in an increase in the body weight.
In this study, there was also a statistically signiˆcant correlation between H1 receptor occupancy and the antipsychotic-induced morbidity rate of diabetes mellitus. With regard to the impaired glucose tolerance induced by atypical antipsychotics, there has been no large-scale prospective study with quantitative indices, such as hemoglobin A1C value, fasting blood sugar level, and oral glucose tolerance test. Therefore, we employed the morbidity rate of diabetes mellitus as the index in this study.
The drug-induced insulin resistance is considered to be caused not only indirectly by the increase in weight, but also by the increased level of leptin. 43, 44) Blockade of the H1 receptor by antipsychotics may impair the function of leptin and consequently evoke leptin resistance and insulin resistance, resulting in impaired glucose tolerance.
The blockade of mACh receptor is known to cause dry mouth. Some researchers have pointed out that anticholinergic dry mouth may lead to an increase in the ingestion of high-calorie beverages and secondarily increase the body weight. 8) However, the a‹nities to mACh receptor of the antipsychotics investigated in this study were very low ( Table 1) , and the correlation of the receptor occupancies between H1 receptor and mACh receptor was high (Table 6 ). Therefore, mACh receptor occupancy is likely to be a confounding factor in the analysis of the cause of antipsychotic-induced weight gain and diabetes mellitus. Indeed, neither remarkable weight gain nor diabetes mellitus has been reported to be associated with the use of typical anticholinergic drugs, such as biperiden or scopolamine.
Therefore, it seems likely that the weight gain and diabetes mellitus associated with antipsychotics are caused by the blockade of the H1 receptor. This conclusion is consistent with the results of Wirshing et al. 45) and Kroeze et al., 46) who have also demonstrated a signiˆcant correlation between weight gain and in vitro dissociation constants of antipsychotics for H1 receptor.
Serotonin has been shown to play an important role in the regulation of appetite and food ingestion. Therefore, it is reasonable that there was a signiˆcant correlation between the 5-HT2C receptor occupancy and the weight gain or the morbidity rate of diabetes mellitus. Nonogaki et al. 47) have reported that 5-HT2C receptor knockout mice become seriously overweight due to increased food ingestion and they secondarily develop insulin resistance. Indeed, stimulation of the 5-HT receptor reduces food ingestion and impaired stimulation of 5-HT receptor increases food ingestion. 48, 49) Both sertindole and olanzapine exhibited remarkable weight gain though the mACh receptor occupancy by these drugs and H1 receptor occupancy by sertindole were quite low (Fig. 1) , possibly due to their high 5-HT2C receptor occupancy (52z and 37z for sertindole and olanzapine, respectivity).
In conclusion, two or more receptors may be involved in the weight gain and diabetes mellitus associated with the use of antipsychotics, but blockade of the H1 receptor by antipsychotics is most likely to be the primary cause of these adverse reactions. The blockade of 5-HT2C receptor may also be involved in these adverse reactions in part.
We cannot show any direct evidences to justify the assumption that the drug concentration in CSF or unbound concentration in plasma is equal to the real CR value, since the real CR value has not been determined in humans. However, drug concentration in CSF is likely to be equal to the plasma unbound concentration for the drug that is not subjected to active transport. Indeed, the plasma unbound fraction of chlorpromazine, haloperidol, thioridazine and mesoridazine are reported to be 0.02-0.05, 50) 0.081, 51) 0.007-0.035 52) and 0.017, 53) respectively, and well agreed with the KpCSF values of these drugs shown in Table 1 . Moreover, it is conceivable that the CR value estimated by using fu and KpCSF is nearly equal to the real CR value because the estimated receptor occupancies of risperidone, olanzapine, quetiapine and haloperidol for D2 and 5-HT2A receptors were in good accordance with the occupancies observed in the positron emission tomography study. 36) Therefore, the above assumption seems to be quite conceivable. However, we cannot exclude the possible discrepancy between the estimated CR value and real one.
We analyzed the relation between the occupancies of various receptors by antipsychotics and the extent of adverse reactions (body weight gain and impaired glucose tolerance) based on receptor occupancy theory, and demonstrated that blockade of the H1 receptor may primarily contribute to these adverse reactions associated with the use of antipsychotics.
